drug

The 'transformative' Lilly drug that could top $25 billion in sales

The ‘transformative’ Lilly drug that could top $25 billion in sales

Eli LilyMounjaro’s potential anti-diabetic drug (LLY) is “risk-free and transformative,” an analyst said Thursday as he updated LLY’s stock. X UBS analyst Colin Bristow now expects Mounjaro to generate more than $25 billion in peak annual sales, about $5 billion more than his previous estimate. The Food and Drug Administration has approved Mounjaro for patients …

The ‘transformative’ Lilly drug that could top $25 billion in sales Read More »

ADHD drug Adderall runs low at Walgreens and CVS as demand soars

ADHD drug Adderall runs low at Walgreens and CVS as demand soars

Drug companies said they didn’t always have Adderall available. “There are supply chain issues with this drug,” Walgreens spokeswoman Rebekah Pajak said. The issues affect both instant-release and time-release Adderall, she said. CVS spokesman Matthew Blanchette said the company’s pharmacies are able to fill Adderall prescriptions “in most cases.” Access all of our coverage with …

ADHD drug Adderall runs low at Walgreens and CVS as demand soars Read More »

FDA panel backs highly controversial ALS drug in rare 2nd review

FDA panel backs highly controversial ALS drug in rare 2nd review

WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend approval of an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the highly controversial drug which was previously rejected by the same group earlier this year. Food and Drug Administration advisers voted 7 to 2 that Amylyx Pharma’s data …

FDA panel backs highly controversial ALS drug in rare 2nd review Read More »

FDA advisers recommend approval of controversial ALS drug

FDA advisers recommend approval of controversial ALS drug

Independent advisers to the Food and Drug Administration voted 7-2 on Wednesday to recommend approval of an experimental ALS drug with strong support from patients and advocates, making it likely the highly controversial treatment will be approved by the agency in a few weeks. The vote was a stunning reversal from late March when the …

FDA advisers recommend approval of controversial ALS drug Read More »